Mortality rates in patients with PsA, psoriasis, RA, and matched controls and the effects of disease-modifying antirheumatic drug (DMARD) prescriptions

Aug-13

Dermatology Pharmacoepidemiology Rheumatology

AUTHORS : Dr Alexis Ogdie, University of Pennsylvania, Division of Rheumatology, 3400 Civic Center Blvd., Philadelphia, Pennsylvania 19104 – Email: alogdie@pennmedicine.upenn.edu – Profile: https://www.cceb.med.upenn.edu/bio/alexis-ogdie-beatty-md-msce

JOURNAL : Journal of Rheumatology

REFERENCE: 40(8):1417

DOI : 10.3899/jrheum.130452

Mortality rates in patients with PsA, psoriasis, RA, and matched controls and the effects of disease-modifying antirheumatic drug (DMARD) prescriptions

More publications

Atopic Dermatitis: Association of maternal and child history of celiac disease and the child’s development of atopic dermatitis

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes